Lucinda Y. Quan

Lucinda Y. Quan is a declared insider of Aligos Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated 20 October 2020.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 20 October 2020, the filings show a transaction in Aligos Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.